Back to top
Franklin Strategic Biotechnology Discovery Fund Class A: (MF: FBDIX)
(NASDAQ Mutual Funds) As of May 10, 2024 08:00 PM ET
$134.27 USD
-1.56 (-1.15%)
Zacks MF Rank
2-Buy of 5 2
Latest Performance as of Apr 30, 2024
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | 4.18 | 21 |
| 3 months | -0.61 | 73 |
| 6 months | 29.64 | 3 |
| 1 Year | 17.67 | 2 |
| 3 Year | -2.41 | 81 |
| 5 Year | 6.48 | 84 |
| 10 Year | 6.31 | 89 |
* Annual for three years and beyond.
Mutual Funds Research & Tools
Search Similar Mutual Funds
Research similar Mutual Funds with higher ranks and performance ratings.
Mutual Funds Comparison View (minimum of 2)
Mutual Funds Screener
Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.
Portfolio Statistics
| % Unrealized Gain | 37.64 |
| % Yield | 0.00 |
| % SEC Yield | NA |
| Net Assets (Mil $) 4/30/2024 | 723.54 |
| % Turnover 4/30/2024 | 24.08 |
Risk
| 3 Year | 5 Year | 10 Year | |
|---|---|---|---|
| Beta | 0.64 | 0.69 | 0.90 |
| Alpha | -7.16 | -1.85 | -2.91 |
| R Squared | 0.31 | 0.35 | 0.36 |
| Std. Dev. | 20.37 | 21.61 | 22.92 |
| Sharpe | -0.16 | 0.31 | 4.00 |
Sector / Country Weightings
| As of 4/30/2024 | % of Portfolio |
|---|---|
| Health | 71.52 |
| Other | 16.41 |
| Technology | 4.31 |
| Services | 3.83 |
| Industrial Cyclical | 3.56 |
| Retail Trade | 0.37 |
Portfolio Holdings
| Top Equity Holdings (As of 1/31/2024) |
% of Portfolio | Value (Mil$) |
|---|---|---|
| AMGEN INC | 8.52 | 76.40 |
| REGENERON PHARMACEUTICALS | 6.81 | 61.06 |
| VERTEX PHARMACEUTICALS IN | 5.95 | 53.32 |
| TOTAL*SHORT TERM INVESTME | 5.49 | 49.16 |
| ASCENDIS PHARMA AS ADR | 3.78 | 33.91 |
| GILEAD SCIENCES INC | 3.61 | 32.39 |
| BIOGEN INC | 3.56 | 31.90 |
| INTRA CELLULAR THERAPIES | 3.25 | 29.12 |
| ASTRAZENECA PLC ADR | 2.95 | 26.41 |
Stock Holding % of Net Assets
| As Of | 1/31/2024 |
| Total Issues | 81 |
| Avg. P/E | 39.40 |
| Avg. P/Book | 4.48 |
| Avg. EPS Growth | 12.37 |
| Avg. Market Value (Mil $) | 50,060 |
Allocation
| % of Portfolio | |
| Large Growth | 0.00 |
| Large Value | 0.00 |
| Small Growth | 34.71 |
| Small Value | 0.00 |
| Foreign Stock | 7.39 |
| Emerging Market | 0.00 |
| Precious Metal | 0.00 |
| Intermediate Bond | 10.22 |
| Foreign Bond | 0.00 |
| High Yield Bond | 0.00 |